PIMCO has long been known as a fixed-income powerhouse with an abundance of investment management talent and enviable track record. They are also one of the most successful purveyors of actively managed exchange-traded funds focused primarily on the bond market to-date.
That dynamic changed recently with the launch of three new multi-factor equity ETFs that successfully complement the existing PIMCO fund lineup. These new funds are backed by a stringent research and stock selection criteria created by Rob Arnott of Research Affiliates, who has a well-respected background in building smart beta portfolios.
These new funds include a combination of U.S. and international exposure broken out in the following buckets:
The term “multi-factor” may seem ambiguous to some, but simply refers to a co-mingling of various investment factor criteria such as value, quality, volatility, size, and momentum. Each of these funds uses a proprietary interplay of those characteristics to create a highly diversified basket of stocks with varying holdings and weights from traditional market-cap weighted indexes.
The multi-factor approach means that these ETFs won’t rely on a single dynamic to drive their security selection and ultimately return profiles. This creates the opportunity for a broader appeal and the ability for investors to implement them as core holdings rather than severely deviating from conventional benchmarks.
For example, MFUS contains nearly 1,000 underlying U.S. stocks with top holdings in Apple (AAPL) and IBM (IBM).The fund charges a reasonable net expense ratio of 0.29% annually and touts the lofty goal of improving excess return potential.
An examination of the upper quartile of the MFUS holdings shows many familiar stocks and others that are generally not as commonplace. The impression is one of a well-balanced, multi-sector portfolio with enough differentiation potential to set itself apart from the likes of the SPDR S&P 500 ETF (SPY) or the iShares Russell 1000 ETF (IWB). The target market being those investors who want alpha potential without going down the road of an over-priced stock picking team with dubious statistical support.
